Information for the public
Rivaroxaban (also known as Xarelto) with aspirin alone, or with aspirin plus clopidogrel, is recommended. It is a possible treatment for adults who have had a certain type of heart problem (acute coronary syndrome with raised cardiac biomarkers).The aim is to prevent further problems, such as heart attack or stroke, caused by blood clots.
If you have had an acute coronary syndrome with raised cardiac biomarkers, and your doctor thinks that rivaroxaban is the right treatment, you should be able to have the treatment on the NHS.
Your doctor should discuss with you the benefits and risks of taking rivaroxaban before starting or continuing treatment. No later than 12 months after starting treatment, your doctor should reassess your condition and make a decision on whether to continue treatment.
Rivaroxaban should be available on the NHS within 3 months of the guidance being issued.